NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation - Wikidata - awgldk - TriplyDB

NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation

NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation

http://www.wikidata.org/entity/Q58420913

about

Nontransfusional approach to increased platelet count in patients with cirrhosis and thrombocytopenia.Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases Low dose of acetylsalicylic acid and oxidative stress-mediated endothelial dysfunction in diabetes: a short-term evaluation.Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis.Management of coagulation abnormalities in liver disease.Low-grade endotoxemia and platelet activation in cirrhosis.Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease.Assessing in vivo platelet activation in patients with liver diseases.Platelets as Modulators of Liver Diseases.New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma Pitfalls in assessing platelet activation status in patients with liver disease: authors’ reply

P2860

Q33407950-209D5DD0-F4CC-4067-9B5B-FBC6B3DAA256 Q33415943-3B6318A2-F6B6-4CB0-9FFC-E39B30EB9187 Q35218036-CAEA6545-A871-4571-B6C2-D50111FDACC0 Q37741459-96C6E456-9322-4CCE-89AE-D7536DA83249 Q38223728-B8135FA7-5A1C-47E0-8B2F-0B6FD354C38F Q40536260-33E6F625-4204-4C9B-88CA-5D55B01AFB31 Q45789410-08E17F55-45FD-41A7-9892-C644F6CB0B57 Q48135303-15034889-9806-4452-983F-906AC4DEF0C9 Q50131013-70954389-7654-4E9A-82F8-382F490C760C Q57482211-CF74189E-4713-4540-A876-356489EBFB72 Q58420892-B2F6475B-C5FD-4EF2-AC52-6773FB89D6AD

P2860

NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation

http://www.wikidata.org/entity/Q58420913

description

article

@en

im August 2011 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2011

@uk

name

NADPH oxidase-mediated platele ...... cation for platelet activation

@en

NADPH oxidase-mediated platele ...... cation for platelet activation

@nl

type

label

NADPH oxidase-mediated platele ...... cation for platelet activation

@en

NADPH oxidase-mediated platele ...... cation for platelet activation

@nl

prefLabel

NADPH oxidase-mediated platele ...... cation for platelet activation

@en

NADPH oxidase-mediated platele ...... cation for platelet activation

@nl

P1433

Q58420913-9F7D2B15-BC40-4249-99AF-FE1D6E51098C

P1476

Q58420913-9371D201-0A1F-4CA3-84CD-83F93CBF2B4F

P2093

Q58420913-7E443402-CB8B-4C6D-A95C-2B503D54E9AC

P2860

Q58420913-0B571417-BD42-4B69-BB8C-4C64BB89682C

Q58420913-0C35EE59-3FF5-454C-B200-C6F011401B67

Q58420913-0FE1EFB1-E36F-4599-A421-E8638D2FFB4B

Q58420913-12C88172-9A86-4E6B-A9F2-EF9F242E1014

Q58420913-18BFBEA2-FA73-48F2-98FA-3DE724C52750

Q58420913-2A7C2BA3-B599-4414-915D-BA76BBBE54C9

Q58420913-4001A283-AF86-4FB2-AA42-139382FC1828

Q58420913-62ECC105-59C1-4C10-92F5-3601619BBB45

Q58420913-688BC571-899F-4A8B-AB51-E1F3484397A2

Q58420913-6AC75F15-F54C-4A70-AF18-7A1A10D42242

P304

Q58420913-F2515DCE-1962-4252-A945-0B84FD3FC4CB

P31

Q58420913-2982A4CD-6DE8-4C96-B93F-80FEA3E88208

P356

Q58420913-84B1A1A6-15EB-4FD0-9605-1B0BAA754E41

P433

Q58420913-0390BF10-3661-4E06-90F4-9B7B1BEF63C8

P478

Q58420913-85CC1FDD-D0AD-4610-A22E-F1D3EDB4E764

P50

Q58420913-1E897376-8FA6-49A7-BB59-A7172621E5FB

Q58420913-2FB2AA68-6629-4D25-B0FE-C1E63E6758D0

Q58420913-6D32E219-28A3-4D45-8C90-FF580888B770

Q58420913-75FFA9A8-5536-4DCB-8CB5-F12120DCACC6

Q58420913-82FAD0AF-8B52-4B2B-A350-AE96E2ABE993

Q58420913-ADDE301F-0656-4B78-9176-7D12FFEB8627

Q58420913-BE60192D-7D4B-43AF-8559-58742AACFE58

Q58420913-FBFE731C-B60C-4610-82A0-5ECFF60BFC9A

P577

Q58420913-84E26FE5-BC88-46D5-9F66-9A8DD1059695

P698

Q58420913-0BBD661B-5217-4074-AB5F-1281399E729D

P356

J.1478-3231.2011.02617.X

P1433

Liver International

P1476

NADPH oxidase-mediated platele ...... cation for platelet activation

@en

P2093

Francesco Angelico

http://www.w3.org/2001/XMLSchema#string

P2860

Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin

Platelets mediate cytotoxic T lymphocyte-induced liver damage.

11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation

gp91phox-dependent expression of platelet CD40 ligand

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Thrombin generation in patients with cirrhosis: the role of platelets.

Thrombocytopenia associated with chronic liver disease.

Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice.

Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease.

The bleeding time as a screening test for evaluation of platelet function.

P304

1533-1540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1478-3231.2011.02617.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Violi

Oliviero Riggio

Roberto Carnevale

Stefania Basili

Valeria Raparelli

Pasquale Pignatelli

Guglielmo Tellan

P577

2011-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22093328

http://www.w3.org/2001/XMLSchema#string